相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel fluoroquinolones containing 2-arylamino-2-oxoethyl fragment: Design, synthesis, evaluation of antibacterial and antituberculosis activities and molecular modeling studies
Necla Kulabas et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2022)
Parametric population pharmacokinetics of linezolid: A systematic review
Yan Qin et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Synthesis of coumarin-thioether conjugates as potential anti-tubercular agents: Their molecular docking and X-ray crystal studies
Mahesh Akki et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
The comparison researches of cis/trans -butenedioic acids in regulating solid crystalline forms and improving pharmaceutical properties of antifungal drug econazole
Meng-Yao Wu et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
Synthesis and antimicrobial evaluation of new nitric oxide-donating fluoroquinolone/oxime hybrids
Hossameldin A. Aziz et al.
ARCHIV DER PHARMAZIE (2021)
Recent update on antibacterial and antifungal activity of quinoline scaffolds
Atukuri Dorababu
ARCHIV DER PHARMAZIE (2021)
HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis
Zeeba Zahra Sultana et al.
BMC INFECTIOUS DISEASES (2021)
Coumarin hybrid derivatives as promising leads to treat tuberculosis: Recent developments and critical aspects of structural design to exhibit anti-tubercular activity
Dinesh S. Reddy et al.
TUBERCULOSIS (2021)
Roles for Structural Biology in the Discovery of Drugs and Agrochemicals Targeting Sterol 14α-Demethylases
Brian C. Monk et al.
JOURNAL OF FUNGI (2021)
Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs
Aditi Chauhan et al.
LIFE SCIENCES (2021)
Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis
Saeed Khoshnood et al.
FRONTIERS IN MICROBIOLOGY (2021)
Standard versus high dose of rifampicin in the treatment of pulmonary tuberculosis: a systematic review and meta-analysis
Lorenzo Onorato et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains
Akanksha Sharma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Chemical Classes Presenting Novel Antituberculosis Agents Currently in Different Phases of Drug Development: A 2010-2020 Review
Klaudia T. Angula et al.
PHARMACEUTICALS (2021)
Contezolid: First Approval
Sheridan M. Hoy
DRUGS (2021)
Oxazolidinone Antibiotics: Chemical, Biological and Analytical Aspects
Claudia Foti et al.
MOLECULES (2021)
Fluoroquinolones: a review on anti-tubercular activity
Sapna Joshi et al.
MONATSHEFTE FUR CHEMIE (2021)
Profiling Pretomanid as a Therapeutic Option for TB Infection: Evidence to Date
Stephani L. Stancil et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in China
Wencong He et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)
Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013-2018
Ashley McDowell et al.
JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES (2021)
Novel nitroimidazole derivatives evaluated for their trypanocidal, cytotoxic, and genotoxic activities
Francisco do Vale Chaves e Mello et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Next-generation drug repurposing using human genetics and network biology
Serguei Nabirotchkin et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
Quinoline-1,3-Oxazole Hybrids: Syntheses, Anticancer Activity and Molecular Docking Studies
Shailesh R. Shah et al.
CHEMISTRYSELECT (2020)
Synthesis and leishmanicidal evaluation of sulfanyl- and sulfonyl-tethered functionalized benzoate derivatives featuring a nitroimidazole moiety
Miguel Rodriguez et al.
ARCHIV DER PHARMAZIE (2020)
Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid
Suha Kadura et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
New tuberculosis drug targets, their inhibitors, and potential therapeutic impact
Gauri S. Shetye et al.
TRANSLATIONAL RESEARCH (2020)
Metformin as Host-Directed Therapy for TB Treatment: Scoping Review
Nikita Naicker et al.
FRONTIERS IN MICROBIOLOGY (2020)
Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis
Arundhati Maitra et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Discovery of a Conformationally Constrained Oxazolidinone with Improved Safety and Efficacy Profiles for the Treatment of Multidrug-Resistant Tuberculosis
Hongyi Zhao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Current advances in the clinical development of anti-tubercular agents
Samanvai Reddy Tetali et al.
TUBERCULOSIS (2020)
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Camus Nimmo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical trials on drug repositioning for COVID-19 treatment
Sandro G. Viveiros Rosa et al.
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH (2020)
Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria
Swetarka Das et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
1H-1,2,3-Triazole tethered isatin-moxifloxacin: Design, synthesis and in vitro anti-mycobacterial evaluation
Yu Jiang et al.
ARCHIV DER PHARMAZIE (2019)
Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis
Shu'an Wen et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
Does linezolid have a role in shortening treatment of tuberculosis?
W. -W. Yew et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Gatifloxacin-1,2,3-triazole-isatin hybrids and their antimycobacterial activities
Zhen Ding et al.
ARCHIV DER PHARMAZIE (2019)
Impact of metformin on the risk and treatment outcomes of tuberculosis in diabetics: a systematic review
Xinyu Yu et al.
BMC INFECTIOUS DISEASES (2019)
Nitroimidazole-containing compounds and their antibacterial and antitubercular activities
Jingyu Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Clofazimine for the treatment of multidrug-resistant tuberculosis
C. Lange et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019
A. D. Pranger et al.
DRUGS (2019)
New Drugs for the Treatment of Tuberculosis
Elisa H. Ignatius et al.
CLINICS IN CHEST MEDICINE (2019)
Improving the odds of drug development success through human genomics: modelling study
Aroon D. Hingorani et al.
SCIENTIFIC REPORTS (2019)
Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval
Emily A. King et al.
PLOS GENETICS (2019)
In vitro and in vivo activity of contezolid (MRX-I) against Mycobacterium tuberculosis
Carolyn Shoen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Clofazimine: A useful antibiotic for drug-resistant tuberculosis
Reza Mirnejad et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Alkylated/aminated nitroimidazoles and nitroimidazole-7-chloroquinoline conjugates: Synthesis and anti-mycobacterial evaluation
Shalini et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Ciprofloxacin derivatives and their antibacterial activities
Gui-Fu Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Synthesis and evaluation of novel coumarin-oxime ethers as potential anti-tubercular agents: Their DNA cleavage ability and BSA interaction study
Dinesh S. Reddy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Should gatifloxacin be included in the model list of essential medicines?
Chen-Yuan Chiang et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
Denise Rossato Silva et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2018)
Synthesis and antimycobacterial evaluation of new (2-oxo-2H-chromen-3-yl) substituted fluoroquinolones
Valery N. Charushin et al.
JOURNAL OF FLUORINE CHEMISTRY (2018)
Repurposing metformin to prevent and treat tuberculosis
Chi Chiu Leung
RESPIROLOGY (2018)
The Expanding Diversity of Mycobacterium tuberculosis Drug Targets
Samantha Wellington et al.
ACS INFECTIOUS DISEASES (2018)
Recent updates of fluoroquinolones as antibacterial agents
Hend A. A. Ezelarab et al.
ARCHIV DER PHARMAZIE (2018)
Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review
David B. Fogel
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2018)
New drugs and perspectives for new anti-tuberculosis regimens
S. Tiberi et al.
PULMONOLOGY (2018)
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
Dennis Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis
Anushka Naidoo et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Drug resistance mechanisms and novel drug targets for tuberculosis therapy
Md Mahmudul Islam et al.
JOURNAL OF GENETICS AND GENOMICS (2017)
7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis
Andrew M. Thompson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis and In Vitro Antimycobacterial and Antibacterial Activity of 8-OMe Ciprofloxacin-Hydrozone/Azole Hybrids
Zhi Xu et al.
MOLECULES (2017)
Discovery of Fluorine-Containing Benzoxazinyl-oxazolidinones for the Treatment of Multidrug Resistant Tuberculosis
Hongyi Zhao et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis
Divakar Sharma et al.
FRONTIERS IN MICROBIOLOGY (2017)
Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review
Vera M. Kroesen et al.
FRONTIERS IN IMMUNOLOGY (2017)
Tuberculosis - drugs in the 2016 development pipeline
Barbara E. Laughon et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Medical Management of Diabesity: Do We Have Realistic Targets?
Joseph M. Pappachan et al.
CURRENT DIABETES REPORTS (2017)
Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of Action
Leonard Amaral et al.
ANTIBIOTICS-BASEL (2017)
Synthesis and evaluation of pretomanid (PA-824) oxazolidinone hybrids
Rakesh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Synthesis, antimycobacterial and antibacterial activity of 1-(6-amino-3,5-difluoropyridin-2-yl) fluoroquinolone derivatives containing an oxime functional moiety
Ju Huang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs
Arundhati Maitra et al.
BRITISH MEDICAL BULLETIN (2016)
Gatifloxacin for short, effective treatment of multidrug-resistant tuberculosis
C-Y. Chiang et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Impact of genetically supported target selection on R&D productivity
Mark R. Hurle et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Preclinical comprehensive physicochemical and pharmacokinetic profiling of novel nitroimidazole derivative IIIM-019-A potential oral treatment for tuberculosis
Gurleen Kour et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2016)
To be or not to be exclusive: the sutezolid story Response
Christy Wyskiel
LANCET GLOBAL HEALTH (2016)
Fluoroquinolone consumption and -resistance trends in Mycobacterium tuberculosis and other respiratory pathogens: Ecological antibiotic pressure and consequences in Pakistan, 2009-2015
S. Shakoor et al.
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY (2016)
Design, synthesis of benzocoumarin-pyrimidine hybrids as novel class of antitubercular agents, their DNA cleavage and X-ray studies
Dinesh S. Reddy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment
Nicholas Winters et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model
U. D. Gupta et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2015)
Repurposing-a ray of hope in tackling extensively drug resistance in tuberculosis
Arundhati Maitra et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis
Rohit Vashisht et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
The support of human genetic evidence for approved drug indications
Matthew R. Nelson et al.
NATURE GENETICS (2015)
A facile synthesis and evaluation of new biomolecule-based coumarin-thiazoline hybrids as potent anti-tubercular agents with cytotoxicity, DNA cleavage and X-ray studies
Dinesh S. Reddy et al.
RSC ADVANCES (2015)
Bactericidal Activity and Mechanism of Action of AZD5847, a Novel Oxazolidinone for Treatment of Tuberculosis
V. Balasubramanian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
DNA Replication Is the Target for the Antibacterial Effects of Nonsteroidal Anti-Inflammatory Drugs
Zhou Yin et al.
CHEMISTRY & BIOLOGY (2014)
Design, Synthesis, and Structure-Activity and Structure-Pharmacokinetic Relationship Studies of Novel [6,6,5] Tricyclic Fused Oxazolidinones Leading to the Discovery of a Potent, Selective, and Orally Bioavailable FXa Inhibitor
Tao Xue et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
Alimuddin I. Zumla et al.
LANCET INFECTIOUS DISEASES (2014)
A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
Corinne S. Merle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Thioridazine for treatment of tuberculosis: Promises and pitfalls
Noton K. Dutta et al.
TUBERCULOSIS (2014)
Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB
Saverio De Lorenzo et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Antitubercular Activity of Disulfiram, an Antialcoholism Drug, against Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Isolates
Yasuhiro Horita et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Classification of scaffold-hopping approaches
Hongmao Sun et al.
DRUG DISCOVERY TODAY (2012)
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials
Ben Gold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties
K. D. Thomas et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Nitroimidazoles for the treatment of TB: past, present and future
Tathagata Mukherjee et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Drug repositioning in the treatment of malaria and TB
Alexis Nzila et al.
FUTURE MEDICINAL CHEMISTRY (2011)
The challenge of new drug discovery for tuberculosis
Anil Koul et al.
NATURE (2011)
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Yves Pommier et al.
CHEMISTRY & BIOLOGY (2010)
Structure-Activity Relationships of Antitubercular Nitroimidazoles. 1. Structural Features Associated with Aerobic and Anaerobic Activities of 4-and 5-Nitroimidazoles
Pilho Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
Jean-Emmanuel Hugonnet et al.
SCIENCE (2009)
Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis
Zahoor Ahmad et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice
Makoto Matsumoto et al.
PLOS MEDICINE (2006)
Azole antifungals as novel chemotherapeutic agents against murine tuberculosis
Zahoor Ahmad et al.
FEMS MICROBIOLOGY LETTERS (2006)
The potential of azole antifungals against latent/persistent tuberculosis
Z Ahmad et al.
FEMS MICROBIOLOGY LETTERS (2006)
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
CK Stover et al.
NATURE (2000)
分享论文
